ENJAYMO Trademark

Trademark Overview

On Wednesday, January 9, 2019, a trademark application was filed for ENJAYMO with the United States Patent and Trademark Office. The USPTO has given the ENJAYMO trademark a serial number of 88255430. The federal status of this trademark filing is REGISTERED as of Tuesday, April 26, 2022. This trademark is owned by Bioverativ Therapeutics Inc.. The ENJAYMO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of cold agglutinin disease
enjaymo

General Information

Serial Number88255430
Word MarkENJAYMO
Filing DateWednesday, January 9, 2019
Status700 - REGISTERED
Status DateTuesday, April 26, 2022
Registration Number6713660
Registration DateTuesday, April 26, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of cold agglutinin disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 30, 2019
Primary Code005
First Use Anywhere DateMonday, February 21, 2022
First Use In Commerce DateMonday, February 21, 2022

Trademark Owner History

Party NameRECORDATI UK LTD
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressHEMEL HEMPSTEAD HP2 4TZ
GB
Party NameBioverativ Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameBioverativ Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameBioverativ Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Monday, April 1, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, January 12, 2019NEW APPLICATION ENTERED
Wednesday, January 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 25, 2019ASSIGNED TO EXAMINER
Monday, April 1, 2019NON-FINAL ACTION WRITTEN
Monday, April 1, 2019NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2019ASSIGNED TO LIE
Wednesday, May 15, 2019ASSIGNED TO LIE
Wednesday, May 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 18, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, September 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 28, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, December 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 12, 2020SOU TEAS EXTENSION RECEIVED
Friday, May 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 29, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020SOU EXTENSION 1 FILED
Tuesday, May 12, 2020SOU EXTENSION 1 GRANTED
Thursday, May 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 7, 2020SOU TEAS EXTENSION RECEIVED
Monday, December 7, 2020SOU EXTENSION 2 FILED
Monday, December 7, 2020SOU EXTENSION 2 GRANTED
Wednesday, December 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, October 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 21, 2021SOU TEAS EXTENSION RECEIVED
Friday, May 21, 2021SOU EXTENSION 3 FILED
Friday, May 21, 2021SOU EXTENSION 3 GRANTED
Tuesday, May 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 13, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, October 13, 2021SOU EXTENSION 4 FILED
Wednesday, October 13, 2021SOU EXTENSION 4 GRANTED
Friday, February 25, 2022USE AMENDMENT FILED
Wednesday, March 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 23, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 24, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 26, 2022REGISTERED-PRINCIPAL REGISTER
Friday, February 25, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, March 23, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 24, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

enjaymo agglutinin disease cold treatment preparation pharmaceutical